Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes.

Biotechnology

Acticor Biotech

Acticor Biotech's headquarters in Paris, France

Yannick Plétan

Kristell Lebozec

Alexandra Brochand

Christelle Lesieur

Bérengère Hennebelle

Anouar Sari

Sirine Bougamra

Violaine Desort-Hénin

Guy Heynen

Catherine Boule

Alain Munoz

Rinaldo Del Bono

Martine Jandrot-Perrus

Jean-Pierre Cazenave

This department oversees corporate governance practices and board-related activities.

Board Governance

The Clinical Operations Team at Acticor Biotech is responsible for planning, executing, and managing clinical trials to develop and validate innovative treatments for ischemic strokes. They ensure compliance with regulatory standards, oversee trial logistics, train clinical staff, and monitor trial progress to ensure data integrity and patient safety.

Clinical Operations Team

The Medical Team at Acticor Biotech is responsible for overseeing clinical trials, developing medical strategies, ensuring regulatory compliance, and providing expert medical guidance to support the development of innovative treatments for ischemic stroke. This team collaborates closely with research, regulatory, and commercial departments to bring safe and effective emergency stroke therapies to market.

Medical Team

The Regulatory and Quality Team at Acticor Biotech ensures that the company's ischemic stroke treatments meet all regulatory requirements and quality standards. This team manages regulatory submissions, compliance, and quality control processes, ensuring that products are safe, effective, and ready for market approval and distribution.

Regulatory and Quality Team

The Scientific & Pharmaceutical Development team at Acticor Biotech is responsible for advancing the company's innovative therapeutic strategy for the emergency treatment of ischemic strokes. The team, comprising experts in scientific research, pharmaceutical development, and business intelligence, works collaboratively to oversee drug development projects, conduct analytical studies, and ensure the integration of scientific advancements into the therapeutic pipeline. Their ultimate goal is to bring a safe and effective treatment to market, improving outcomes for ischemic stroke patients.

Scientific & Pharmaceutical Development

The Leadership Team at Acticor Biotech is responsible for setting the strategic direction and vision of the company, ensuring alignment with its mission to develop innovative treatments for ischemic strokes. Comprising key executives including the CEO, CFO, and Chief Medical Officers, the team drives decision-making, oversees operational management, and fosters collaboration among scientific founders to advance research and development efforts. Their collective expertise guides the organization's growth and positions it as a leader in stroke treatment innovation.

Acticor Biotech

Org chart

Board & advisors

Teams

Board Governance

Clinical Operations Team

Medical Team

Regulatory and Quality Team

Scientific & Pharmaceutical Development

Leadership Team

Offices

Acticor Biotech

Org chart

Board & advisors

Teams

Board Governance

Clinical Operations Team

Medical Team

Regulatory and Quality Team

Scientific & Pharmaceutical Development

Leadership Team

Offices

Related companies